Chinese Coptionnical Trial Register (ChiCTR) - The world health organization international coptionnical trials registered organization registered platform

简体中文|English

Trial search

Nation, Province(City)

Measure

Ethical committee

Study type

Trial search

reset

Public title

Scientific title

Subject ID

Registration Status

Registration number

Secondary ID

Applicant

Study leader

Year

Primary sponsor

Secondary sponsor

Source(s) of funding

Target disease

Target disease code

Study type

Study phase

Study design

Recruiting status

Execute time(From)

Execute time(END)

Sign the informed consent

Gender

Nation(Area)

Province

City

Unit (hospital)

Institution

Level of the institution

Intervention

Intervention code

Approved by ethic committee

Calculated Results after the Study Completed puboptionc access

9 trials have been registered

Historical versions	Registration number	Public title	Type	Registration time
Historical Versions	ChiCTR2600120457	Pivotal study to evaluate YL202 versus Docetaxel in Patients with Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer Shanghai Dongfang Hospital	Interventional study	2026/03/16
Historical Versions	ChiCTR2500106103	A Phase Ⅰb/Ⅲ Clinical Study of SYS6010 in combination with Osimertinib in patients with locally advanced or metastatic NSCLC Shanghai Chest Hospital	Interventional study	2025/07/17
Historical Versions	ChiCTR2400091938	Study on the Effects of Hydrogen-Oxygen Therapy and Aerobic Exercise on Cognitive and Brain Function in Healthy Individuals Jiangsu Vocational College of Medicine	Interventional study	2024/11/06
Historical Versions	ChiCTR2400086735	A multi-center, randomized, double-blinded, placebo-controlled phase II clinical study to evaluate the efficacy and safety of CF04 ophthalmic solution in the treatment of moderate to severe dry eye syndrome The Second Affiliated Hospital Zhejiang University School of Medicine	Interventional study	2024/07/09
Historical Versions	ChiCTR2200058131	Effects of food on pharmacokinetic characteristics of YZJ-1139 tablets (40mg) in Healthy Chinese subjects Affiliated Hospital of Liaoning University of Traditional Chinese Medicine	Interventional study	2022/03/30
Historical Versions	ChiCTR2100045813	Phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics following single or repeated oral administration of BS1801 in healthy adult volunteers Shulan (Hangzhou) Hospital Co., Ltd.	Interventional study	2021/04/25
Historical Versions	ChiCTR2100044302	[14C]YZJ-1139 Absorption, Metabolism and Excretion Clinical Trials in Chinese Adult Male Healthy Subjects-[14C]YZJ-1139 Research on Human Material Balance and Biotransformation The First Affiliated Hospital of Soochow University	Interventional study	2021/03/16
Historical Versions	ChiCTR2000040596	A randomized, double-blind, multiple-dose, two-cycle, parallel bioequivalence pilot trial of daunorubicin cytosine abysaccharide liposome for injection in older, first-treated AML subjects Hematology Hospital of Chinese Academy of Medical Sciences	Interventional study	2020/12/03
Historical Versions	ChiCTR2000039903	A Phase 3, Multicenter, Randomized, Double–Blinded and Placebo–Controlled Study Evaluating the Efficacy and Safety of 0.25% HBM9036 (HL036) Ophthalmic Solution Compared to Placebo in Chinese Subjects with Moderate and Severe Dry Eye Xiamen Eye Center Affiliated to Xiamen University	Interventional study	2020/11/14

Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform

蜀ICP备16010396号-9

Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later